Focus diagnosis and therapeutics on the inflammatory markers, as atherosclerosis starts as intravascular inflammation
Lynch L, Hogan AE, Duquette D, Lester C, Banks A, LeClair K, et al
September 2014
ATTAIN-2 enrolled over 1,600 adults with type 2 diabetes and showed meaningful weight reductions of 5.1 to 9.6 percent depending on dose, along with significant improvements in blood sugar control and cardiometabolic markers including waist circumference, blood pressure, and cholesterol
Oral GLP-1 Pills: The Next Generation of Weight Loss Medication Oral semaglutide, a pill form of the same active ingredient found in Ozempic and Wegovy, is changing how patients approach medical weight loss